 |
| Lisa Davidson |
Lisa Davidson exits her role as managing director at Havas Health & You to become executive VP and lead for client services and global business development at Bliss Bio Health, the Next Practices Group’s life sciences marketing communications firm. She will be based in the firm’s New York office.
Before coming on board at Havas in 2020, Davidson held leadership positions at BCW, Burson-Marsteller and Porter Novelli.
She brings expertise in pre-clinical and clinical educational campaigns, advocacy development, product marketing, medical devices, reputation, and issues management.
Davidson’s hiring follows the January appointment of Gloria Vanderham to serve as CEO of both Next Practices Group Health and Bliss Bio Health.
“Our team and clients will benefit from Lisa’s deep experience in working ‘from atom to access’ with both integrated agency teams and healthcare companies in a wide range of disease areas,” said Vanderham. “Lisa will help us redefine the life sciences and healthcare marketing communications landscape.”
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
Charlie Chapman, a policy advisor to Health & Human Services Secretary Robert Kennedy Jr., has joined BGR’s health & life sciences practice.
The future of DTC should foster understanding and trust, as well as improving clinical conversations.
